Skip to main content

Gulf War and Health, Volume 11: Generational Health Effects of Serving in the Gulf War

Completed

In response to health concerns of Gulf War veterans, Congress in 1998 directed the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to evaluate the scientific and medical literature regarding associations between illness and exposure to the toxic agents, environmental and wartime hazards, and preventive medicines and vaccines associated with Gulf War service.

Description

An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will conduct a study to assess the current research available on possible generational health effects that may be the result of exposures experienced by Veterans of the 1990-1991 Gulf War and the Post 9/11 wars during their deployments. The committee will consider which toxicants, including but not limited to burning oil wells, pesticides, nerve agents, prophylactic agents, depleted uranium, and vaccines, are known to be associated with pathophysiological and reproductive, developmental, and teratogenic effects across the life course in parents, offspring, and second generation offspring.
In addition, the committee will also assess areas requiring further scientific study on the descendants of Veterans with toxic exposures. Finally, the committee will further assess the scope and methodology required to conduct research on such descendants to identify current or possible health effects in the Veterans’ descendants, including but not limited to:

  • Cellular pathophysiology studies associated with the long-term generational health effects of the toxicants of concern (among these, the committee should consider studies in laboratory animals and other models);
  • Multigenerational effects of the toxicants of concern in various animal species, if such effects have not already been well-established;
  • The feasibility of conducting a long-term epidemiologic study to assess the generational health effects of Veterans and the resources (technological, logistical) that would need to be available to support such research;
  • Develop a framework for monitoring and studying generational health effects over time, including post-exposure assessments, initial screening of Veterans and their descendants, the frequency and duration of such screenings;
  • Based upon a careful assessment of available laboratory technologies, establish a process for what is to be included in the screening including biomarkers and early symptoms;
  • The number of Veterans and their descendants who should be part of such a study(ies); and
  • The appropriate federal agency(ies), e.g., the Department of Defense, the Department of Veterans Affairs, Department of Health and Human Services, or other organization(s) or collaboratives that would be best suited to coordinate and/or conduct the research and screenings on an ongoing basis.

Collaborators

Committee

Chair

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Sponsors

Department of Veterans Affairs

Other, Federal

Staff

Roberta Wedge

Lead

Tameika Cheri Banks

Cary Haver

Major units and sub-units

Health and Medicine Division

Lead

Board on the Health of Select Populations

Lead

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.